Awridian will be attending this 1 day meeting focusing on Recent Trends in Medicinal Chemistry and Enabling Technologies. The programme will cover a combination of medicinal chemistry, drug discovery enabling technologies and chemical biology.
With confirmed speakers from AstraZeneca, Domainex, GSK, Molecular Horizon, OpenADMET, Pharmaron, Sygnature Discovery and the University of Leiden, the meeting will reflect the breadth of work taking place to advance our understanding and prosecution of targets, technologies and lead series to underpin medicines research. Hope to see you there .